Conceptio › Archive › HAL (France)
HAL (France)open access

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Laurence Buisseret et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326119
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.